The AACR poster presentation will provide an update on the data in AML patients most recently presented at the American Society of Hematology (ASH) Annual Meeting 2024 showing that ICT01 administered ...

COURTESY KAPIOLANI MEDICAL CENTER FOR WOMEN & CHILDREN Aurelia Awa, 11, of Ewa Beach has been named the 2025 Children’s Miracle Network Hospitals Champion. On the right, Aurelia is pictured with her ...

Rgenta Therapeutics, a clinical-stage biotechnology company pioneering the development of a new class of oral small molecules ...

Fintel reports that on March 25, 2025, Maxim Group upgraded their outlook for Moleculin Biotech (NasdaqCM:MBRX) from Hold to ...

Owen Dangelser from Davenport is a teen who likes to be active and ride his skateboard. He likes music and playing video ...

EQS-News: Eckert & Ziegler SE / Key word (s): Agreement/Incoming Orders Eckert & Ziegler to Supply Actinium Pharmaceuticals with Ac-225 for Comprehensive Development Activities 25.03.2025 / 09:30 ...

Dale Odegaard (85) passed away March 19, 2025 at Our Lady of Peace Hospice in St. Paul, MN. He had several health issues over the last two years with a final diagnosis of Acute Myeloid Leukemia (AML).

HC Wainwright reissued their buy rating on shares of Moleculin Biotech (NASDAQ:MBRX – Free Report) in a research note ...

Q4 2024 Earnings Call Transcript March 24, 2025 Operator: Hello, and welcome to the Moleculin Biotech Fourth Quarter and Full ...

A hair salon boss from Poulton who was making good progress after a leukemia diagnosis 18 months ago has been given the ...

Discover how Moleculin Biotech advances Annamycin's Phase 3 trial for AML treatment, with key milestones planned through 2025.